The company recycles non-ferrous metal scrap, primarily lead and copper, into refined ingots and value-added products like anodes and cathodes for industrial customers globally.
The company lacks a wide moat as evidenced by low net margins (5.2%) and high sensitivity to LME price fluctuations. While it has a scale advantage in sourcing from 120 countries and LME-registered quality, the business remains a price-taking commodity processor with negative cash conversion.
Management is aggressively reinvesting in forward integration (copper cathodes, wire rods) and international joint ventures (Kuwait, Ahmedabad). While ROCE is healthy at 18.7%, the high EPS decline relative to revenue growth suggests capital intensity is currently outpacing earnings power.
The company collapsed under the weight of its own aggressive expansion as capital intensity permanently decoupled from earnings power. The negative cash conversion cycle, already visible in the filings, became a terminal liquidity trap when LME price volatility compressed the thin 5% margins. Management's history of diverting IPO proceeds to promoters and engaging in unapproved related-party transactions foreshadowed a total breakdown in governance, leading to a loss of creditor confidence and a fire sale of the newly integrated copper assets.
RichFakir rates Jain Resource Recycling Ltd's business quality as decent — 57/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Jain Resource Recycling Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Jain Resource Recycling Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Jain Resource Recycling Ltd's fair value is about ₹115 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →